MDxHealth
MDXH
5 hedge funds and large institutions have $24.5M invested in MDxHealth in 2022 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and 3 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.04% less ownership
Funds ownership: 1.97% → 1.92% (-0.04%)
16% less capital invested
Capital invested by funds: $29.1M → $24.5M (-$4.53M)
29% less funds holding
Funds holding: 7 → 5 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$2.64K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Altium Capital Management
New York
|
-$344K |
| 2 |
GCM
Ghisallo Capital Management
Boston,
Massachusetts
|
-$190K |
| 3 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$63.5K |
| 4 |
Morgan Stanley
New York
|
-$15K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BL
1
Bleichroeder LP
New York
| $16.3M | – | – | – |
|
|
MPU
2
MVM Partners (UK)
London,
United Kingdom
| $7.23M | – | – | – |
|
|
PCM
3
Perkins Capital Management
Wayzata,
Minnesota
| $747K | – | – | – |
|
|
4
Hudson Bay Capital Management
Stamford,
Connecticut
| $306K | -$63.5K | -7,324 | -17% |
|
|
5
UBS Group
Zurich,
Switzerland
| $3K | +$2.64K | +305 | New |
|
|
ACM
6
Altium Capital Management
New York
| – | -$344K | -36,159 | Closed |
|
|
GCM
7
Ghisallo Capital Management
Boston,
Massachusetts
| – | -$190K | -20,000 | Closed |
|
|
8
Morgan Stanley
New York
| – | -$15K | -1,526 | Closed |
|
MDXH Hedge Fund Activity: Q1 2022 in Review
5 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in MDxHealth (MDXH) for Q1 2022, worth a combined $24.5M — down 16% from $29.1M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of MDXH and 1 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 0 added.
The largest buyer was UBS Group, opening a new position worth an estimated $2.64K. The largest seller was Altium Capital Management, exiting entirely with an estimated $344K sold.
- 5 institutional investors held MDxHealth (MDXH) as of Q1 2022, down from 7 in Q4 2021.
- Funds reported $24.5M of MDxHealth stock for Q1 2022, down 16% quarter-over-quarter.
- 1 fund opened new MDxHealth positions in Q1 2022 and 3 closed out, a net change of -2 holders.
- The largest MDxHealth buyer in Q1 2022 was UBS Group, an estimated $2.64K added.
- The largest MDxHealth seller in Q1 2022 was Altium Capital Management, an estimated $344K sold.
Based on aggregated 13F filings for Q1 2022.